Mutated Ras-Transfected, EBV-Transformed Lymphoblastoid Cell Lines as a Model Tumor Vaccine for Boosting T-Cell Responses Against Pancreatic Cancer: A Pilot Trial-Reference-Cited by-同舟云学术

Mutated Ras-Transfected, EBV-Transformed Lymphoblastoid Cell Lines as a Model Tumor Vaccine for Boosting T-Cell Responses Against Pancreatic Cancer: A Pilot Trial

Published:2012-12 Issue:12 Volume:23 Page:1224-1236
ISSN:1043-0342
Container-title:Human Gene Therapy
language:en
Short-container-title:Human Gene Therapy

Author:

Kubuschok Boris¹,Pfreundschuh Michael¹,Breit Rainer¹,Hartmann Frank¹,Sester Martina²,Gärtner Barbara³,König Jochem⁴,Murawski Niels¹,Held Gerhard¹,Zwick Carsten¹,Neumann Frank¹

Affiliation:

1. Department of Internal Medicine I, Jose-Carreras Centrum for Immuno- and Gene Therapy, University of Saarland Medical School, D-66421 Homburg/Saar, Germany.

2. Department of Internal Medicine IV, University of Saarland Medical School, D-66421 Homburg/Saar, Germany.

3. Department of Virology, University of Saarland Medical School, D-66421 Homburg/Saar, Germany.

4. Institute of Medical Biostatistics, Epidemiology and Informatics, Division of Medical Biometry, University Medical Center, Johannes Gutenberg University Mainz, 55131 Mainz, Germany.

Publisher

Mary Ann Liebert Inc

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/hum.2011.153

Reference50 articles.

1. Oncogenic Ras-Induced Expression of Cytokines: A New Target of Anti-Cancer Therapeutics

2. Specific human cytotoxic T cells recognize B-cell lines persistently infected with respiratory syncytial virus.

3. Molecular Mechanisms of Resistance to Cetuximab and Panitumumab in Colorectal Cancer

4. Integrin-linked kinase is a central mediator in angiotensin II type 1- and chemokine receptor CXCR4 signaling in myocardial hypertrophy

5. Dendritic Cells Initiate Immune Control of Epstein-Barr Virus Transformation of B Lymphocytes In Vitro

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune modulators for pancreatic ductal adenocarcinoma therapy;Immune Landscape of Pancreatic Cancer Development and Drug Resistance;2024

2. The clinical terrain of immunotherapies in heterogeneous pancreatic cancer: unravelling challenges and opportunities;The Journal of Pathology;2023-08

3. Immunotherapy in Pancreatic Cancer;Pancreatic Cancer;2023

4. The Next Frontier in Pancreatic Cancer: Targeting the Tumor Immune Milieu and Molecular Pathways;Cancers;2022-05-25

5. Pancreatic Cancer and Immunotherapy: A Clinical Overview;Cancers;2021-08-17